Dopaminergic activation of Fos and the rat model of Parkinson's disease.
Cole
D G
DG
Department of Neurology, Massachusetts General Hospital, Boston 02114.
D000818:Animals; D001931:Brain Mapping; D003342:Corpus Striatum / Q000503:physiopathology; D004292:Dominance, Cerebral / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D009434:Neural Pathways / Q000502:physiology; D010302:Parkinson Disease, Secondary / Q000235:genetics* / Q000503:physiopathology; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics* / Q000502:physiology; D051381:Rats; D011954:Receptors, Dopamine / Q000235:genetics* / Q000502:physiology; D013378:Substantia Nigra / Q000503:physiopathology; D009435:Synaptic Transmission / Q000235:genetics / Q000502:physiology
D016760:Proto-Oncogene Proteins c-fos; D011954:Receptors, Dopamine; D004298:Dopamine